Pharmacological Approaches in Cancer Treatment: A Comprehensive Guide presents an in-depth exploration of pharmacological approaches utilized in cancer treatment. The book's overarching theme revolves around understanding the intricate mechanisms and applications of various therapies, ranging from targeted treatments to immunotherapies. Through examination and analysis, the content sheds light on emerging trends and breakthroughs in the field, providing a comprehensive overview of cancer pharmacology. Sections target therapies, chemotherapy agents, immunotherapy, personalized medicine, combination therapies, drug resistance, novel drug delivery systems, palliative care in oncology, adverse effects of cancer pharmacotherapy, and preclinical studies.
Each chapter provides the nuances of its respective subject matter, providing readers with a thorough understanding of the scientific underpinnings and practical applications of cancer pharmacology. Designed to cater to both oncology professionals and patients, this book serves as a valuable resource for enhancing understanding and informing treatment decisions.
Each chapter provides the nuances of its respective subject matter, providing readers with a thorough understanding of the scientific underpinnings and practical applications of cancer pharmacology. Designed to cater to both oncology professionals and patients, this book serves as a valuable resource for enhancing understanding and informing treatment decisions.
Table of Contents
1. Targeted Therapies: Mechanisms and Applications2. Chemotherapy Agents: Current and Emerging Options
3. Immunotherapy: Harnessing the Immune System in Cancer Treatment
4. Personalized Medicine: Pharmacogenomics and Cancer Therapy
5. Combination Therapies: Synergistic Approaches in Cancer Treatment
6. Drug Resistance: Mechanisms and Strategies to Overcome
7. Novel Drug Delivery Systems for Cancer Therapy
8. Palliative Care in Oncology: Symptom Management and Supportive Therapies
9. Adverse Effects of Cancer Pharmacotherapy: Prevention and Management
10. Preclinical Studies: Translational Research in Drug Development
Authors
Sadhna Aggarwal MD Anderson Cancer Center, TX, USA. Dr. Aggarwal is currently a senior postdoctoral fellow at the MD Anderson Cancer Center, Texas, USA. She completed Ph.D. from AIIMS, New Delhi under supervision of Prof. S. N. Das. During PhD, wherein she successfully addressed various aspects of local immunopathology in oral squamous cell carcinoma (OSCC). She published dozens of articles and several book chapters. She is an editorial board member of several indexed reputed international journals. Phulen Sarma Department of Clinical Pharmacology, All India Institute of Medical Sciences (AIIMS), Guwahati, Assam, India. Dr. Phulen Sarma is an Assistant Professor in the Department of Pharmacology at AIIMS Guwahati.He completed his MBBS and MD in Pharmacology from Assam Medical College, Dibrugarh, and
subsequently obtained a DM in Clinical Pharmacology from the prestigious PGIMER, Chandigarh.
He serves as Principal Investigator of the Technical Resource Centre, DHR Centre for Evidence-Based
Guidelines at AIIMS Guwahati, and has contributed significantly to the development of national
evidence-based guidelines, including the Stem Cell and Lung Cancer Guidelines.
